Clinical Trial Update: Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing multiple-dose pharmacokinetics and pharmacodynamics of NSI-189 Phosphate in adults with depression; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NSI-189 Phosphate (NSI-189 phosphate)

Snippet

Sponsor: Neuralstem Inc. | Conditions: Depression | Phase 1 | Status: COMPLETED